↓ Skip to main content

JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis

Overview of attention for article published in BMC Infectious Diseases, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
4 news outlets
twitter
7 X users

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
171 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis
Published in
BMC Infectious Diseases, January 2021
DOI 10.1186/s12879-020-05730-z
Pubmed ID
Authors

Lucas Walz, Avi J. Cohen, Andre P. Rebaza, James Vanchieri, Martin D. Slade, Charles S. Dela Cruz, Lokesh Sharma

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 171 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 12%
Researcher 20 12%
Other 17 10%
Student > Bachelor 16 9%
Student > Doctoral Student 14 8%
Other 34 20%
Unknown 49 29%
Readers by discipline Count As %
Medicine and Dentistry 51 30%
Pharmacology, Toxicology and Pharmaceutical Science 13 8%
Nursing and Health Professions 12 7%
Immunology and Microbiology 11 6%
Biochemistry, Genetics and Molecular Biology 9 5%
Other 23 13%
Unknown 52 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2021.
All research outputs
#1,256,713
of 23,274,744 outputs
Outputs from BMC Infectious Diseases
#293
of 7,790 outputs
Outputs of similar age
#36,309
of 504,225 outputs
Outputs of similar age from BMC Infectious Diseases
#6
of 170 outputs
Altmetric has tracked 23,274,744 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,790 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 504,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 170 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.